{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:28Z","timestamp":1707524308682},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,22]]},"DOI":"10.7759\/cureus.16570","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T23:17:26Z","timestamp":1626995846000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatocellular Carcinoma in a Patient With Crohn\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Akira","family":"Hokama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Arakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Ishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souhei","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Agarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuwae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Zukeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuji","family":"Maeshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuma","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhisa","family":"Takatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13265","article-title":"Hepatic manifestations of inflammatory bowel diseases","volume":"37","author":"Restellini S","year":"2017","unstructured":"Restellini S, Chazouill\u00e8res O, Frossard JL. Hepatic manifestations of inflammatory bowel diseases. Liver Int. 2017, 37:475-89. 10.1111\/liv.13265","journal-title":"Liver Int"},{"key":"ref2","article-title":"Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine","volume":"30","author":"Lee FL","year":"1983","unstructured":"Lee FL, Murray SM, Prior J, Shreeve DR. Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine. Hepatogastroenterology. 1983, 30:188.","journal-title":"Hepatogastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2000.7629","article-title":"Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy","volume":"31","author":"Cattan S","year":"2000","unstructured":"Cattan S, Wendum D, Chazouilleres O, Schmitz J, Gendre JP. Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy. Hum Pathol. 2000, 31:874-6. 10.1053\/hupa.2000.7629","journal-title":"Hum Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1023\/a:1011915032118","article-title":"Unusual development of hepatocellular carcinoma in a patient with Crohn's disease","volume":"46","author":"Borum ML","year":"2001","unstructured":"Borum ML. Unusual development of hepatocellular carcinoma in a patient with Crohn's disease. Dig Dis Sci. 2001, 46:2199-200. 10.1023\/a:1011915032118","journal-title":"Dig Dis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.07.041","article-title":"Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report","volume":"36","author":"Oya H","year":"2004","unstructured":"Oya H, Sato Y, Yamamoto S, Takeishi T, Kobayashi T, Hatakeyama K. Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report. Transplant Proc. 2004, 36:2297-8. 10.1016\/j.transproceed.2004.07.041","journal-title":"Transplant Proc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-9009-9","article-title":"Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab","volume":"51","author":"Chen SC","year":"2006","unstructured":"Chen SC, Cummings OW, Hartley MP, Filomena CA, Cho WK. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab. Dig Dis Sci. 2006, 51:952-5. 10.1007\/s10620-005-9009-9","journal-title":"Dig Dis Sci"},{"key":"ref7","article-title":"Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report","volume":"53","author":"Demarchi B","year":"2007","unstructured":"Demarchi B, Bresso F, Novero D, et al.. Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. Minerva Gastroenterol Dietol. 2007, 53:279-83.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9613-3","article-title":"Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine","volume":"52","author":"Samarasena J","year":"2007","unstructured":"Samarasena J, Borgaonkar M. Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine. Dig Dis Sci. 2007, 52:2748-50. 10.1007\/s10620-006-9613-3","journal-title":"Dig Dis Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1866","article-title":"Hepatocellular carcinoma and Crohn's disease: a case report and review","volume":"48","author":"Miura H","year":"2009","unstructured":"Miura H, Kawaguchi T, Takazoe M, Kitamura S, Yamada H. Hepatocellular carcinoma and Crohn's disease: a case report and review. Intern Med. 2009, 48:815-9. 10.2169\/internalmedicine.48.1866","journal-title":"Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2009.02399.x","article-title":"Hepatocellular carcinoma occurring in a young Crohn's disease patient","volume":"59","author":"Murakami A","year":"2009","unstructured":"Murakami A, Tanaka Y, Ueda M, et al.. Hepatocellular carcinoma occurring in a young Crohn's disease patient. Pathol Int. 2009, 59:492-6. 10.1111\/j.1440-1827.2009.02399.x","journal-title":"Pathol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i25.3215","article-title":"Hepatocellular carcinoma occurring in a Crohn's disease patient","volume":"16","author":"Ishida M","year":"2010","unstructured":"Ishida M, Naka S, Shiomi H, et al.. Hepatocellular carcinoma occurring in a Crohn's disease patient. World J Gastroenterol. 2010, 16:3215-8. 10.3748\/wjg.v16.i25.3215","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/340836","article-title":"Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review","volume":"2014","author":"Fortinsky KJ","year":"2014","unstructured":"Fortinsky KJ, Alali A, Jeejeebhoy K, Fischer S, Sherman M, Fung S. Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review. Case Rep Gastrointest Med. 2014, 2014:340836. 10.1155\/2014\/340836","journal-title":"Case Rep Gastrointest Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/939136","article-title":"Recurrent hepatocellular carcinoma in patient with Crohn's disease: incidental or expected outcome of azathioprine?","volume":"2015","author":"Botros Y","year":"2015","unstructured":"Botros Y, Mathews M, Patel H, Shah N, Baddoura W, de la Torre A. Recurrent hepatocellular carcinoma in patient with Crohn's disease: incidental or expected outcome of azathioprine?. Case Rep Gastrointest Med. 2015, 2015:939136. 10.1155\/2015\/939136","journal-title":"Case Rep Gastrointest Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4067","article-title":"Hepatocellular carcinoma regression after cessation of immunosuppressive therapy","volume":"34","author":"Kumar A","year":"2016","unstructured":"Kumar A, Le DT. Hepatocellular carcinoma regression after cessation of immunosuppressive therapy. J Clin Oncol. 2016, 34:e90-2. 10.1200\/JCO.2013.51.4067","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000444012","article-title":"Resected hepatocellular carcinoma in a patient with Crohn's disease on azathioprine","volume":"10","author":"Heron V","year":"2016","unstructured":"Heron V, Fortinsky KJ, Spiegle G, Hilzenrat N, Szilagyi A. Resected hepatocellular carcinoma in a patient with Crohn's disease on azathioprine. Case Rep Gastroenterol. 2016, 10:50-6. 10.1159\/000444012","journal-title":"Case Rep Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i29.5282","article-title":"From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world","volume":"23","author":"Dimitroulis D","year":"2017","unstructured":"Dimitroulis D, Damaskos C, Valsami S, et al.. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017, 23:5282-94. 10.3748\/wjg.v23.i29.5282","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21416","article-title":"Cancer in Crohn's disease patients treated with infliximab: a long-term multicenter matched pair study","volume":"17","author":"Biancone L","year":"2011","unstructured":"Biancone L, Petruzziello C, Orlando A, et al.. Cancer in Crohn's disease patients treated with infliximab: a long-term multicenter matched pair study. Inflamm Bowel Dis. 2011, 17:758-66. 10.1002\/ibd.21416","journal-title":"Inflamm Bowel Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2046","article-title":"Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data","volume":"20","author":"Askling J","year":"2011","unstructured":"Askling J, Fahrbach K, Nordstrom B, Ross S, Schmid CH, Symmons D. Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf. 2011, 20:119-30. 10.1002\/pds.2046","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v9.i13.613","article-title":"Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease","volume":"9","author":"Tran-Minh ML","year":"2017","unstructured":"Tran-Minh ML, Sousa P, Maillet M, Allez M, Gornet JM. Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World J Hepatol. 2017, 9:613-26. 10.4254\/wjh.v9.i13.613","journal-title":"World J Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1241","article-title":"Hepatobiliary cancer risk in patients with inflammatory bowel disease: a Scandinavian population-based cohort study","volume":"30","author":"Erichsen R","year":"2021","unstructured":"Erichsen R, Ol\u00e9n O, Sachs MC, et al.. Hepatobiliary cancer risk in patients with inflammatory bowel disease: a Scandinavian population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2021, 30:886-94. 10.1158\/1055-9965.EPI-20-1241","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60880-hepatocellular-carcinoma-in-a-patient-with-crohns-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:14Z","timestamp":1707506834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60880-hepatocellular-carcinoma-in-a-patient-with-crohns-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.16570","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}